Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28

被引:17
作者
Dankers, MKA
Roelen, DL
Van Der Meer-Prins, EMW
De Lange, P
Korfage, N
Smits, JMA
Persijn, GG
Welsh, KI
Doxiadis, IIN
Claas, FHJ
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands
[2] Eurotransplant Fdn, Leiden, Netherlands
[3] Univ London Imperial Coll Sci Technol & Med, Dept Clin Genom, London, England
关键词
D O I
10.1097/01.TP.0000044456.51462.E2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunogenicity of human leukocyte antigen (HILA)-A2 versus HLA-A28 was analyzed by antibody production, cytotoxic T-lymphocyte (CTL) induction, and graft survival. We observed that an HLA-A2 mismatched child in HLA-A28(+) women leads to HLA-A2 specific antibodies in 32% of the women (n=31), whereas in the case of an HLA-A28(+) child and HLA-A2(+) women (n=30), no HLA-A28 specific antibodies were found (P<0.002). Also, the CTL precursor frequencies were significantly lower against HLA-A28 compared with CTLp frequencies against HLA-A2 (P=0.012). Finally, the kidney graft survival was slightly better in HLA-A2 positive recipients transplanted with HLA-A28 mismatches. We can conclude that single HLA-A28 mismatches are less immunogenic in HLA-A2 individuals compared with single HLA-A2 mismatches in HLA-A28 individuals, which is probably because the mismatched epitopes on the HLA-A2 molecule are unique epitopes, whereas the mismatched epitopes on HLA-A28 are shared by other HLA-A and HLA-B molecules.
引用
收藏
页码:418 / 420
页数:3
相关论文
共 10 条
[1]   DETERMINATION OF CYTOTOXIC LYMPHOCYTE-T PRECURSOR FREQUENCIES USING EUROPIUM LABELING AS A NONRADIOACTIVE ALTERNATIVE TO LABELING WITH CHROMIUM-51 [J].
BOUMA, GJ ;
VANDERMEERPRINS, PMW ;
VANBREE, FPMJ ;
VANROOD, JJ ;
CLAAS, FHJ .
HUMAN IMMUNOLOGY, 1992, 35 (02) :85-92
[2]   Association between specific HLA combinations and probability of kidney allograft loss: The taboo concept [J].
Doxiadis, IIN ;
Smits, JMA ;
Schreuder, GMT ;
Persijn, GG ;
vanHouwelingen, HC ;
vanRood, JJ ;
Claas, FHJ .
LANCET, 1996, 348 (9031) :850-853
[3]   HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. I. Description of the algorithm [J].
Duquesnoy, RJ .
HUMAN IMMUNOLOGY, 2002, 63 (05) :339-352
[4]   HLAMmatchmaker: A molecularly based donor selection algorithm for highly alloimmunized patients [J].
Duquesnoy, RJ .
TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) :493-497
[5]   SPECIFICITY POCKETS FOR THE SIDE-CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68 [J].
GARRETT, TPJ ;
SAPER, MA ;
BJORKMAN, PJ ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1989, 342 (6250) :692-696
[6]   CELLULAR MECHANISMS OF ALLOGRAFT-REJECTION [J].
HUTCHINSON, IV .
CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (05) :722-728
[7]  
Maruya E, 1993, Clin Transpl, P511
[8]   Permissible and immunogenic HLA-A mismatches: Cytotoxic T-cell precursor frequencies reflect graft survival data [J].
Roelen, DL ;
Stobbe, I ;
Young, NT ;
van Bree, SPMJ ;
Doxiadis, IIN ;
Oudshoorn, M ;
Morris, PJ ;
Wood, KJ ;
Claas, FHJ .
HUMAN IMMUNOLOGY, 2001, 62 (07) :661-667
[9]   FACTORS CONTRIBUTING TO LONG-TERM KIDNEY GRAFT-SURVIVAL IN EUROTRANSPLANT [J].
THOROGOOD, J ;
VANHOUWELINGEN, JC ;
VANROOD, JJ ;
ZANTVOORT, FA ;
SCHREUDER, GMT ;
PERSIJN, GG .
TRANSPLANTATION, 1992, 54 (01) :152-158
[10]   The impact of HLA-A matching on long-term survival of renal allografts [J].
Zantvoort, FA ;
DAmaro, J ;
Persijn, GG ;
Cohen, B ;
Schreuder, GMT ;
vanRood, JJ ;
Thorogood, J .
TRANSPLANTATION, 1996, 61 (05) :841-844